Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.63 |
| ▸ | CETP | P11597 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | IDO1 | P14902 | 1/20 | 0.44 |
| ▸ | SRC | P12931 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.43 |
| ▸ | MTOR | P42345 | 1/20 | 0.43 |
| ▸ | AGXT | P21549 | 1/20 | 0.43 |
| ▸ | ALPG | P10696 | 1/20 | 0.43 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.41 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.41 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.41 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11288205 | 0.90 | TSHR (0.53) | TSHRCETPALDH1A1FOLH1LMNA | |
| SCHEMBL5269070 | 0.90 | TSHR (0.57) | TSHRCETPALDH1A1IDO1SRC | |
| SCHEMBL7384000 | 0.89 | TSHR (0.52) | TSHRCETPALDH1A1SRCNPC1 | |
| SCHEMBL2415748 | 0.88 | TSHR (0.55) | TSHRCETPALDH1A1IDO1SRC | |
| SCHEMBL698590 | 0.86 | TSHR (0.63) | TSHRCETPALDH1A1IDO1SRC | |
| SCHEMBL8519322 | 0.86 | TSHR (0.53) | TSHRCETPSRC | |
| SCHEMBL7431191 | 0.84 | L3MBTL1 (0.51) | TSHRCETPIDO1FOLH1 | |
| SCHEMBL4586530 | 0.83 | TSHR (0.50) | TSHRCETPALDH1A1FOLH1 | |
| SCHEMBL6752075 | 0.83 | TSHR (0.70) | TSHRCETPALDH1A1SRCNPC1 | |
| SCHEMBL12746424 | 0.83 | TSHR (0.59) | TSHRCETPALDH1A1IDO1SRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 685 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121673323-B | Sulfide ore collecting agent based on thiophene-amide-sodium phosphate salt, and preparation method and application thereof | CHANGCHUN GOLD RESEARCH INSTITUTE Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| EP-4720050-A1 | PROCESS OF PREPARING HIV CAPSID INHIBITOR | GILEAD SCIENCES, INC. (US) | 2026-04-08 | — | — | EP | claimed |
| EP-4074719-B1 | NEW-TYPE OXAZOLIDINONE COMPOUNDS AND PREPARATION METHOD THEREFOR | HC SYNTHETIC PHARMACEUTICAL CO LTD (CN) | 2025-12-03 | — | — | EP | claimed |
| CN-120005406-A | Flame-retardant functional silicone rubber for cable accessories and preparation method thereof | 深圳市正安有机硅材料有限公司 | 2025-05-16 | — | — | CN | claimed |
| CN-119463391-A | High-strength flame-retardant plastic-wood board and manufacturing process thereof | 美新科技股份有限公司 | 2025-02-18 | — | — | CN | claimed |
| US-12173020-B2 | New-type oxazolidinone compounds and preparation method therefor | HC Synthetic Pharmaceutical Co., Ltd. (CN) | 2024-12-24 | — | — | US | claimed |
| CN-119143832-A | Abiraterone acetate and preparation method thereof | 黄冈人福药业有限责任公司 | 2024-12-17 | — | — | CN | claimed |
| WO-2024249672-A1 | PROCESS OF PREPARING HIV CAPSID INHIBITOR | GILEAD SCIENCES, INC. (US) | 2024-12-05 | — | — | WO | claimed |
| CN-118165433-A | Polyvinyl chloride power pipe and preparation process thereof | 安徽海通塑胶科技有限公司 | 2024-06-11 | — | — | CN | claimed |
| CN-117567455-A | Novel oxazolidinone compound and synthetic method and application thereof | 华创合成制药股份有限公司 | 2024-02-20 | — | — | CN | claimed |
| EP-0652226-A1 | Process of preparing etoposide phosphate and etoposide | Bristol-Myers Squibb Company (US) | 1995-05-10 | — | — | EP | claimed |
| EP-0172581-B1 | DISACCHARIDE DERIVATIVES | DAIICHI SEIYAKU CO., LTD. (JP) | 1992-05-06 | — | — | EP | claimed |
| US-5066794-A | Coupling monosaccharides, phosphonation, protecting, deprotecting | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 1991-11-19 | — | — | US | claimed |
| EP-0167204-B1 | METHOD FOR IMPROVING THE ABSORPTION AND EFFECTIVENESS OF A CATECHOLAMINE COMPOUND | SIMES S.p.A. Società Italiana Medicinali e Sintetici (IT) | 1989-09-27 | — | — | EP | claimed |
| EP-0150883-B1 | PROCESS FOR PREPARING N-(DIBENZYLOXYPHOSPHORYL)-CYANAMIDE AND PROCESSES USING SAID COMPOUNDS AS INTERMEDIATE FOR THE SYNTHESIS OF PHOSPHAGEN SUBSTANCES | F.I.S. FABBRICA ITALIANA SINTETICI S.p.A. (IT) | 1989-04-19 | — | — | EP | claimed |
| EP-0172581-A2 | Disaccharide derivatives | DAIICHI SEIYAKU CO., LTD. (JP) | 1986-02-26 | — | — | EP | claimed |
| EP-0167204-A1 | Method for improving the absorption and effectiveness of a catecholamine compound | SIMES S.p.A. Società Italiana Medicinali e Sintetici (IT) | 1986-01-08 | — | — | EP | claimed |
| EP-0150883-A2 | Process for preparing N-(dibenzyloxyphosphoryl)-cyanamide and processes using said compounds as intermediate for the synthesis of phosphagen substances | F.I.S. FABBRICA ITALIANA SINTETICI S.p.A. (IT) | 1985-08-07 | — | — | EP | claimed |
| EP-0051819-B1 | TETRA-SUBSTITUTED BENZENE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1985-02-13 | — | — | EP | claimed |
| EP-0051819-A2 | Tetra-substituted benzene derivatives, their preparation and pharmaceutical preparations containing them | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1982-05-19 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12173020-B2 | New-type oxazolidinone compounds and preparation method therefor | CYP4F11, OXA1L, WEE2 | TSHR 3107/4885CETP 2341/4885ALDH1A1 1468/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.